InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,449.96
(
0.04%
)
US TECH 100
19,086.76
(
0.68%
)
Dow Jones
39,056.70
(
-0.90%
)
Brent Oil
84.49
(
-0.92%
)
Bitcoin
61,496.87
(
2.05%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JediMozart

Send PM Follow Ignore
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

JediMozart

Member Level

Re: None

Tuesday, 06/01/2021 1:07:49 PM

Tuesday, June 01, 2021 1:07:49 PM

Post# of 13742
"We have been ramping up production of Escozine(R) in recent weeks as we prepared for the important step of marketing Escozine(R) to patients throughout the DR," said Medolife CEO Dr. Arthur Mikaelian. "We are now ready to ship from our first batch of medical Escozine(R), produced through our in-house reservation and production facility, and we've put the customer service mechanisms in place to handle such business. This is all very exciting and just another step in growing our distribution footprint of Escozine(R)."

8:00a ET 6/1/2021 - Globe Newswire
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up